Russia maintains a historic low in mortality from cardiovascular diseases
For the
past two years, the Russian Federation has maintained a historic low in
mortality from cardiovascular diseases. This was announced by Deputy Minister
of Healthcare of the Russian Federation Yevgeny Kamkin during the business
programme of the 4th National Congress with international participation "National Healthcare" as part of the plenary session "Heart of
the Nation 2.0" at the National Centre RUSSIA.
The
Congress is organised by the Ministry of Healthcare of the Russian Federation
and the Roscongress Foundation, with the Russian Research Institute of Health
(RIH) of the Ministry of Healthcare of Russia acting as the organisational
partner.
Cardiovascular
diseases remain the main cause of premature mortality both in Russia and
globally, with coronary heart disease, myocardial infarction and stroke playing
a key role. The development of such pathologies is influenced by numerous risk
factors. Some of them — such as genetic predisposition and age-related changes
— are beyond human control. However, others, including unhealthy lifestyles,
smoking and high levels of "bad" cholesterol, are classified as
preventable (modifiable) and can be corrected.
"Cardiovascular
diseases are among the leading causes of death and factors influencing life
expectancy in Russia. Therefore, the efforts we are directing towards reducing
their prevalence have become key elements in our strategy to improve the
quality and longevity of citizens’ lives. Thanks primarily to the
implementation of the Federal Project ‘Combating Cardiovascular Diseases’ and
the work of the healthcare system as a whole, over the past two years we have
maintained a record low mortality rate from cardiovascular diseases,"
emphasised Deputy Minister of Healthcare of the Russian Federation Yevgeny Kamkin.
The session
also featured Director General of the Chazov National Medical Research Centre
of Cardiology of the Ministry of Healthcare of the Russian Federation and Chief
Freelance Cardiologist of the Ministry of Healthcare of the Russian Federation
Sergei Boytsov; Chief Freelance Specialist in Anaesthesiology and Intensive
Care of the Moscow Department of Healthcare and Director of the Moscow
Multidisciplinary Clinical Centre Kommunarka Denis Protsenko; Chairman of the
Academic Council of the MEDSI Group and Head of the Centre for Diagnostics and
Innovative Medical Technologies of the MEDSI Clinical and Diagnostic Centre
Gennady Konovalov; Chairman of the Healthcare Committee of Saint Petersburg
Andrei Sarana; and Development Director of the ORBI Stroke Foundation
Yekaterina Milova. The session was moderated by VGTRK TV presenter and
Editor-in-Chief of the Doctor TV channel Evelina Zakamskaya.
The new
national project "Long and Active Life" aims to become the main
driver in achieving the national goal of increasing life expectancy. Among the
most successful and dynamically developing measures of the national project is
the drug provision programme, which since its launch has helped save tens of
thousands of lives, proving its high efficiency. Under the project, patients
who have suffered a heart attack, stroke or undergone heart surgery receive
free medication for two years. However, in practice, a significant proportion
of patients discontinue therapy on their own once initial improvements appear,
which increases the risk of recurrent heart attacks and early disability. This
situation requires not only additional measures to improve treatment adherence
but also broader control over modifiable risk factors, among which
dyslipidaemia remains a leading one.
During the
discussion, experts addressed several key questions: how to improve early
diagnosis of cardiovascular diseases in patients, what strategies and
approaches are needed to enhance the effectiveness of the new project to combat
cardiovascular diseases, what factors influence patients’ adherence to
prescribed therapy, and which initiatives are required to achieve a large-scale
reduction in mortality from cardiac diseases.
